ELVN |
Enliven Therapeutics, Inc. |
Aug 29, 2024 |
2 |
-$270K |
4 |
Sep 3, 2024 |
CHIEF SCIENTIFIC OFFICER |
ELVN |
Enliven Therapeutics, Inc. |
Jul 31, 2024 |
1 |
-$85.4K |
4 |
Aug 2, 2024 |
CHIEF SCIENTIFIC OFFICER |
ELVN |
Enliven Therapeutics, Inc. |
Jul 29, 2024 |
2 |
-$320K |
4 |
Jul 31, 2024 |
CHIEF SCIENTIFIC OFFICER |
ELVN |
Enliven Therapeutics, Inc. |
Jul 1, 2024 |
1 |
-$275K |
4 |
Jul 3, 2024 |
CHIEF SCIENTIFIC OFFICER |
ELVN |
Enliven Therapeutics, Inc. |
May 29, 2024 |
4 |
-$247K |
4 |
May 31, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 29, 2024 |
4 |
-$202K |
4 |
May 1, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 11, 2024 |
3 |
-$718K |
4 |
Apr 15, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 1, 2024 |
5 |
-$210K |
4 |
Apr 3, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 29, 2024 |
4 |
-$184K |
4 |
Mar 4, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 13, 2024 |
1 |
$0 |
4 |
Feb 15, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Jan 29, 2024 |
3 |
-$177K |
4 |
Jan 31, 2024 |
CHIEF SCIENTIFIC OFFICER, Director |
ELVN |
Enliven Therapeutics, Inc. |
Dec 29, 2023 |
4 |
-$158K |
4 |
Jan 3, 2024 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Dec 21, 2023 |
6 |
-$78.4K |
4 |
Dec 26, 2023 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Dec 19, 2023 |
6 |
-$106K |
4 |
Dec 21, 2023 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Nov 3, 2023 |
3 |
-$102K |
4 |
Nov 6, 2023 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Sep 29, 2023 |
3 |
-$150K |
4 |
Oct 3, 2023 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Apr 4, 2023 |
1 |
$0 |
4 |
Apr 6, 2023 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 23, 2023 |
3 |
$0 |
4 |
Feb 27, 2023 |
Chief Scientific Officer, Director |
ELVN |
Enliven Therapeutics, Inc. |
Feb 23, 2023 |
0 |
$0 |
3 |
Feb 27, 2023 |
Chief Scientific Officer, Director |